Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* fever above 37.5°c by the time when the participant is randomised; a participant excluded for transient acute illness may be dosed if the illness resolves by the time of randomisation. * history of infection with sars or mers * any drug therapy within 7 days prior to day 1	* fever above 37.5°c by the time when the participant is randomised; a participant excluded for transient acute illness may be dosed if the illness resolves by the time of randomisation. * history of infection with sars or mers * any drug therapy within 7 days prior to day 1
May 25, 2021, 12:32 a.m.	usa	- fever above 37.5°c by the time when the participant is randomised; a participant excluded for transient acute illness may be dosed if the illness resolves by the time of randomisation. - history of infection with sars or mers - any drug therapy within 7 days prior to day 1	- fever above 37.5°c by the time when the participant is randomised; a participant excluded for transient acute illness may be dosed if the illness resolves by the time of randomisation. - history of infection with sars or mers - any drug therapy within 7 days prior to day 1